NEXAVAR (sorafenib) for Unresectable Hepatocellular Carcinoma and Advanced Renal Cell Carcinoma - Cancer Therapy Advisor

NEXAVAR (sorafenib) for Unresectable Hepatocellular Carcinoma and Advanced Renal Cell Carcinoma

Slideshow

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

This slideshow reviews drug information for NEXAVAR (sorafenib), indicated for unresectable hepatocellular carcinoma and advanced renal cell carcinoma.
Table of Contents
Slide 3: Indication, Dosage, and Administration
Slide 7: Use in Specific Populations
Slide 9: Clinical Pharmacology
Slide 13: Warnings and Precautions
Slide 17: Clinical Safety and Efficacy
Slide 26: Drug Storage and Supply
Slide 28: References

Next hm-slideshow in Slides